Skip to main content

Table 1 Inclusion, exclusion and PICO (Population Intervention Comparison and Outcome) criteria for this review

From: The composition of cell-based therapies obtained from point-of-care devices/systems which mechanically dissociate lipoaspirate: a scoping review of the literature

Inclusion criteria

Exclusion criteria

-Published articles in English or with translation freely available (from any period)

-Full text accessibility

-Study designs (any of): Randomised control trials (RCTs), non-RCTs, prospective and retrospective cohort studies, cross-sectional studies, case–control studies, case series

-Adipose tissue obtained from animals or cadavers

-Enzyme use prior to device/system administration or enzymatic-based devices/systems

-Devices/systems involved in lipotransfer or the harvesting process of adipose tissue eg. AquaVage, and LipiVage [78]

-Case reports, review articles, abstracts, letters and non-peer reviewed articles

-Studies reported in any other language apart from English with no translation

PICO criteria

Population

Human subjects (any age) including source of adipose tissue

Intervention/Exposure

Use of commercially available devices and systems to mechanically process lipoaspirate to obtain fresh cells

Control/Comparator

Any other lipoaspirate-processing technique

Outcome(s)

Primary

Cell concentration at point of isolation, without further expansion in culture

Secondary

Cell viability, phenotypic analysis and clinical application of the cellular product